Dr. Steven Fletcher’s new grant fuels collaborative training bridging chemistry and biology at UMSOP and UMBC.

Study will explore how an antibiotic-resistant bacterium survives in the body and how that knowledge could lead to new, more effective treatments.

Researchers are developing a novel therapy using safe, drug-free nanoparticles to aid the body in fighting sepsis more effectively.

New study sheds light on how disease progression and biomolecular corona affect nanoparticle-mediated immune activation.

Pharmaceutical scientist aims to foster continued collaborations and drive interdisciplinary research.